Nitric oxide: Difference between revisions
No edit summary |
No edit summary |
||
Line 292: | Line 292: | ||
<!--Drug box 2--> | <!--Drug box 2--> | ||
|drugBox={{ | |drugBox={{Chembox2 | ||
| verifiedrevid = 394799714 | | verifiedrevid = 394799714 | ||
| ImageFileL1 = Nitric-oxide-2D.png | | ImageFileL1 = Nitric-oxide-2D.png | ||
Line 390: | Line 390: | ||
}} | }} | ||
}} | }} | ||
|mechAction=* | |mechAction=* | ||
Revision as of 17:44, 22 December 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];
Disclaimer
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
Black Box Warning
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
|
Overview
Nitric oxide is a {{{drugClass}}} that is FDA approved for the {{{indicationType}}} of {{{indication}}}. There is a Black Box Warning for this drug as shown here. Common adverse reactions include .
Adult Indications and Dosage
FDA-Labeled Indications and Dosage (Adult)
Condition1
- Dosing Information
- Dosage
Condition2
- Dosing Information
- Dosage
Condition3
- Dosing Information
- Dosage
Condition4
- Dosing Information
- Dosage
Off-Label Use and Dosage (Adult)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Nitric oxide in adult patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Nitric oxide in adult patients.
Pediatric Indications and Dosage
FDA-Labeled Indications and Dosage (Pediatric)
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding FDA-Labeled Use of Nitric oxide in pediatric patients.
Off-Label Use and Dosage (Pediatric)
Guideline-Supported Use
Condition1
- Developed by:
- Class of Recommendation:
- Strength of Evidence:
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Guideline-Supported Use of Nitric oxide in pediatric patients.
Non–Guideline-Supported Use
Condition1
- Dosing Information
- Dosage
Condition2
There is limited information regarding Off-Label Non–Guideline-Supported Use of Nitric oxide in pediatric patients.
Contraindications
- Condition1
Warnings
ConditionName:
See full prescribing information for complete Boxed Warning.
ConditionName:
|
- Description
Precautions
- Description
Adverse Reactions
Clinical Trials Experience
There is limited information regarding Clinical Trial Experience of Nitric oxide in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Postmarketing Experience
There is limited information regarding Postmarketing Experience of Nitric oxide in the drug label.
Body as a Whole
Cardiovascular
Digestive
Endocrine
Hematologic and Lymphatic
Metabolic and Nutritional
Musculoskeletal
Neurologic
Respiratory
Skin and Hypersensitivy Reactions
Special Senses
Urogenital
Miscellaneous
Drug Interactions
- Drug
- Description
Use in Specific Populations
Pregnancy
- Pregnancy Category
- Australian Drug Evaluation Committee (ADEC) Pregnancy Category
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Nitric oxide in women who are pregnant.
Labor and Delivery
There is no FDA guidance on use of Nitric oxide during labor and delivery.
Nursing Mothers
There is no FDA guidance on the use of Nitric oxide with respect to nursing mothers.
Pediatric Use
There is no FDA guidance on the use of Nitric oxide with respect to pediatric patients.
Geriatic Use
There is no FDA guidance on the use of Nitric oxide with respect to geriatric patients.
Gender
There is no FDA guidance on the use of Nitric oxide with respect to specific gender populations.
Race
There is no FDA guidance on the use of Nitric oxide with respect to specific racial populations.
Renal Impairment
There is no FDA guidance on the use of Nitric oxide in patients with renal impairment.
Hepatic Impairment
There is no FDA guidance on the use of Nitric oxide in patients with hepatic impairment.
Females of Reproductive Potential and Males
There is no FDA guidance on the use of Nitric oxide in women of reproductive potentials and males.
Immunocompromised Patients
There is no FDA guidance one the use of Nitric oxide in patients who are immunocompromised.
Administration and Monitoring
Administration
- Oral
- Intravenous
Monitoring
There is limited information regarding Monitoring of Nitric oxide in the drug label.
- Description
IV Compatibility
There is limited information regarding IV Compatibility of Nitric oxide in the drug label.
Overdosage
Acute Overdose
Signs and Symptoms
- Description
Management
- Description
Chronic Overdose
There is limited information regarding Chronic Overdose of Nitric oxide in the drug label.
Pharmacology
Template:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox entryTemplate:Chembox 3DMetTemplate:Chembox ECNumberTemplate:Chembox E numberTemplate:Chembox GmelinTemplate:Chembox RTECSTemplate:Chembox UNNumberTemplate:Chembox AppearanceTemplate:Chembox DensityTemplate:Chembox MeltingPtTemplate:Chembox BoilingPtTemplate:Chembox SolubilityInWaterTemplate:Chembox SolubilityTemplate:Chembox RefractIndexTemplate:Chembox StructureTemplate:Chembox ThermochemistryTemplate:Chembox PharmacologyTemplate:Chembox MainHazardsTemplate:Chembox RPhrasesTemplate:Chembox SPhrasesTemplate:Chembox NFPATemplate:Chembox FlashPtTemplate:Chembox SupplementTemplate:Chembox header2 | Nitric oxide | |
---|---|
Identifiers | |
| |
3D model (JSmol)
|
|
ChEBI | |
ChemSpider | |
DrugBank | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
KEGG | |
PubChem CID
|
|
UNII | |
| |
| |
Properties | |
NO | |
Molar mass | 30.006 g/mol |
Hazards | |
Related compounds | |
Template:Chembox header2 | Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
Mechanism of Action
Structure
Pharmacodynamics
There is limited information regarding Pharmacodynamics of Nitric oxide in the drug label.
Pharmacokinetics
There is limited information regarding Pharmacokinetics of Nitric oxide in the drug label.
Nonclinical Toxicology
There is limited information regarding Nonclinical Toxicology of Nitric oxide in the drug label.
Clinical Studies
There is limited information regarding Clinical Studies of Nitric oxide in the drug label.
How Supplied
Storage
There is limited information regarding Nitric oxide Storage in the drug label.
Images
Drug Images
{{#ask: Page Name::Nitric oxide |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
Package and Label Display Panel
{{#ask: Label Page::Nitric oxide |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
Patient Counseling Information
There is limited information regarding Patient Counseling Information of Nitric oxide in the drug label.
Precautions with Alcohol
- Alcohol-Nitric oxide interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.
Brand Names
- ®[1]
Look-Alike Drug Names
- A® — B®[2]
Drug Shortage Status
Price
References
The contents of this FDA label are provided by the National Library of Medicine.
- ↑ Empty citation (help)
- ↑ "http://www.ismp.org". External link in
|title=
(help)
{{#subobject:
|Page Name=Nitric oxide |Pill Name=No image.jpg |Drug Name= |Pill Ingred=|+sep=; |Pill Imprint= |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}} |Pill Color=|+sep=; |Pill Shape= |Pill Size (mm)= |Pill Scoring= |Pill Image= |Drug Author= |NDC=
}}
{{#subobject:
|Label Page=Nitric oxide |Label Name=Nitric oxide11.png
}}
{{#subobject:
|Label Page=Nitric oxide |Label Name=Nitric oxide11.png
}}
- Pages with script errors
- Pages with empty citations
- CS1 errors: external links
- Chemical articles with multiple compound IDs
- Multiple chemicals in an infobox that need indexing
- Chemical articles with multiple CAS registry numbers
- Chemical articles with multiple PubChem CIDs
- Chemical articles with unknown parameter in Chembox
- ECHA InfoCard ID from Wikidata
- Chembox having DSD data
- Pages with broken file links
- Drug